Prevalence and variations in gastric emptying delay in response to GLP ‐1 receptor agonist liraglutide
Obesity · 2024-02 · 32 (2) · 232-233
DOI: 10.1002/oby.23941 ↗At a glance
Leserbrief in Obesity, published online on 2023-11-05. Written by Michael Camilleri and 2 co-authors. Institution: Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Division of Gastroenterology and Hepatology, Mayo Clinic, Rocheste…. Major MEDLINE topics: Diabetes Mellitus, Type 2, Liraglutide. Cited 37 times so far (Crossref); 4 references. The full text is freely available in PubMed Central. Funded by: NIDDK NIH HHS, National Institutes of Health.
Abstract (original language)
Ebda abstract disponibbli.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
ORCID profiles: Michael Camilleri
Funding
- NIDDK NIH HHS
- National Institutes of Health
Cite
APA
Camilleri, M., Carlson, P., & Dilmaghani, S. (2024). Prevalence and variations in gastric emptying delay in response to GLP ‐1 receptor agonist liraglutide. Obesity, 32(2), 232-233. https://doi.org/10.1002/oby.23941
Vancouver
Camilleri M, Carlson P, Dilmaghani S. Prevalence and variations in gastric emptying delay in response to GLP ‐1 receptor agonist liraglutide. Obesity. 2024;32(2):232-233. doi:10.1002/oby.23941
BibTeX
@article{Camilleri2024,
author = {Camilleri, Michael and Carlson, Paula and Dilmaghani, Saam},
title = {Prevalence and variations in gastric emptying delay in response to GLP ‐1 receptor agonist liraglutide},
journal = {Obesity},
year = {2024},
volume = {32},
number = {2},
pages = {232--233},
doi = {10.1002/oby.23941}
}
EUVIMED